stella
beta
A Study to Evaluate D-0502 in Subjects With ER+ Her2- Locally Advanced or Metastatic Breast Cancer — Stella
Recruiting
Back to Breast Cancer trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(2 sites)
China
Cancer Hospital Chinese Academy of Medical Science, Beijing, Beijing Municipality
Harbin Medical University Cancer Hospital, Harbin, Heilongjiang
View full record on ClinicalTrials.gov